Cargando…

Takotsubo syndrome in a patient after renal transplantation

BACKGROUND: Takotsubo syndrome (TTS) is a transient cardiomyopathy of unknown origin, clinically manifesting as acute coronary syndrome (ACS). This syndrome mainly occurs in postmenopausal women and has a temporary relationship with emotional or physical stress. CASE REPORT: TTS occurred in 46-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chrapko, Beata E., Tomaszewski, Andrzej, Jaroszyński, Andrzej J., Furmaga, Jacek, Wysokiński, Andrzej, Rudzki, Sławomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560759/
https://www.ncbi.nlm.nih.gov/pubmed/22367133
http://dx.doi.org/10.12659/MSM.882510
Descripción
Sumario:BACKGROUND: Takotsubo syndrome (TTS) is a transient cardiomyopathy of unknown origin, clinically manifesting as acute coronary syndrome (ACS). This syndrome mainly occurs in postmenopausal women and has a temporary relationship with emotional or physical stress. CASE REPORT: TTS occurred in 46-year-old female patient on the first day after renal transplantation. The predominant symptoms were connected with ACS, performed with low grade troponin elevation and characteristic shape of left ventricle depicted in echocardiography. Taking into consideration the risk of the development of contrast-induced nephropathy, coronary angiography (CA) was delayed; myocardial perfusion scintigraphy and iodine-123 metaiodobenzylguanidine ((123)I-mIBG) myocardial uptake were performed to confirm the clinical suspicion. Myocardial perfusion scintigraphy (MPS) performed in rest condition showed normal perfusion but myocardial uptake of (123)I-mIBG was impaired. Within 6 months after surgery, full recovery of all biochemical and functional parameters of the left ventricle were observed. At that time CA was done, depicting normal coronary arteries. CONCLUSIONS: TTS could be diagnosed by the use of non-nephrotoxic tests – (123)I-mIBG myocardial scintigraphy, MPS and echocardiography.